Showing 1 - 4 results of 4 for search 'Papa A. Diaw', query time: 0.03s Refine Results
  1. 1
    Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal

    Establishing a national laboratory quality system for HIV diagnosis and monitoring in resource-limited settings: Experience from Senegal by Mouhamed A.S. Mbengue, Moussa Sarr, Papa A. Diaw, Papa A. N. Diallo, Maimouna D. Toure, Ndeye F.F.N. Faye, Bousso Gueye, Ndeye C.T. Kane, Souleymane Mboup

    Published 2016-10-01
    Get full text
    Article
  2. 2
    HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients

    HIV and Tuberculosis co-infection impacts T-cell activation markers but not the numbers subset of regulatory T-cells in HIV-1 infected patients by Moustapha Mbow, Ndèye S.S. Santos, Makhtar Camara, Awa Ba, Aliou Niang, Géraldine Daneau, Djibril Wade, Abdou A. Diallo, Maxim Toupane, Maïmouna Diakhaté, Nafissatou Lèye, Papa A. Diaw, Souleymane Mboup, Luc Kestens, Tandakha N. Dieye

    Published 2013-09-01
    Get full text
    Article
  3. 3
    Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects.

    Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Naïve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects. by Tandakha N. Dieye, Birahim P. NDiaye, Alle B. Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A. Diaw, Coumba Toure-Kane, Papa S. Sow, Souleymane Mboup, Helen McShane

    Published 2013-01-01
    Get full text
    Article
  4. 4
    Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects.

    Two doses of candidate TB vaccine MVA85A in antiretroviral therapy (ART) naïve subjects gives comparable immunogenicity to one dose in ART+ subjects. by Tandakha N Dieye, Birahim P Ndiaye, Alle B Dieng, Marema Fall, Nathaniel Brittain, Samantha Vermaak, Makhtar Camara, Halimatou Diop-Ndiaye, Ndeye Fatou Ngom-Gueye, Papa A Diaw, Coumba Toure-Kane, Papa S Sow, Souleymane Mboup, Helen McShane

    Published 2013-01-01
    Get full text
    Article

Search Tools: